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ttp://dx.doi.org/10.1016/j.ajpath.2013.02.032After wounding, multiple cell types interact to form a ﬁbrovascular scar; the formation and cellular origins
of these scars are incompletely understood. We used a laser-injury wound model of choroidal neo-
vascularization in the eye to determine the spatiotemporal cellular events that lead to formation of
a ﬁbrovascular scar. After laser injury, F4/80þ myeloid cells inﬁltrate the wound site and induce smooth
muscle actin (SMA) expression in adjacent retinal pigment epithelial cells, with subsequent formation of
a SMAþNG2þ myoﬁbroblastic scaffold, into which endothelial cells then inﬁltrate to form a ﬁbrovascular
lesion. Cells of the ﬁbrovascular scaffold express the proangiogenic factor IL-1b strongly, whereas retinal
pigment epithelial cells are the main source of VEGF-A. Subsequent choroidal neovascularization is
limited to the area demarcated by this myoﬁbroblastic scaffold and occurs independently of epithelial- or
myeloid-derived VEGF-A. The SMAþNG2þ myoﬁbroblastic cells, F4/80þ macrophages, and adjacent
epithelial cells actively proliferate in the early phase of the wound healing response. Cell-lineage tracing
experiments suggest that the SMAþNG2þ myoﬁbroblastic scaffold originates from choroidal pericyte-like
cells. Targeted ablation of macrophages inhibits the formation of this ﬁbrovascular scaffold, and
expression analysis reveals that these macrophages are Arg1þYM1þF4/80þ alternatively activated
M2-like macrophages, which do not require IL-4/STAT6 or IL-10 signaling for their activation. Thus,
macrophages are essential for the early wound healing response and the formation of a ﬁbrovascular scar.
(Am J Pathol 2013, 182: 2407e2417; http://dx.doi.org/10.1016/j.ajpath.2013.02.032)Supported by NIH-NEI grant R01-EY019297 (A.G.M.).The acute wound healing response after injury is a complex
process involving multiple cell types that interact in a highly
coordinated fashion to form a ﬁbrovascular scar. The cell
types and the spatiotemporal events involved in the process
of forming a ﬁbrovascular scar are tissue-speciﬁc and are not
well understood. We used an acute wound healing model of
choroidal neovascularization (CNV) in the eye to determine
the spatiotemporal cellular events that lead to the formation
of a ﬁbrovascular scar and used cell-lineage tracing and
various genetic mouse models to determine cell type-speciﬁc
functions in this process. This mouse wound healing model is
a frequently used experimental model for CNV, the cardinal
feature of neovascular (often called wet) age-related macular
degeneration (AMD), and involves a laser-induced acute
wounding of the retinal pigment epithelium (RPE)echoroid
interface with disruption of the RPE focally.1 In this exper-
imental model, a myeloid cell inﬁltrate occurs early after laser
injury and is followed by the formation of neovessels, whichstigative Pathology.
.originate mainly from the choroidal vasculature.2 It has been
proposed that macrophages affect this neovascularization
process. Clodronate liposomeeinduced ablation of macro-
phages inhibited CNV lesion formation2; however, others
have suggested that macrophages promote CNV, and thus the
role of macrophages in this model is not well understood.3
Although some studies suggest that macrophages can
undergo transdifferentiation into endothelial cells during
induced angiogenesis, it is not known whether macrophages
that accumulate locally at the site of laser injury undergo
endothelial transdifferentiation and incorporate into neo-
vessels in CNV.4,5 Whether macrophages undergo activation
in CNV lesions and polarize to either an M1- or M2-type
macrophage population also remains to be determined;
however, in tumor angiogenesis, a proangiogenic role of
alternatively activated M2-type macrophages that express
He and Marnerosmultiple proangiogenic growth factors and cytokines has
been proposed.6 Similarly, it has been suggested that the
proangiogenic growth factor VEGF-A is critical for CNV
formation and that inﬁltrating macrophages express VEGF-A
and promote angiogenesis in neovascular AMD,7 but others
have found VEGF-A expression only in RPE cells in neo-
vascular AMD lesions, but not in macrophages.8 Thus,
whether macrophages promote CNV lesions through VEGF-A
expression is not known and has not been shown in this laser-
injury model.
Importantly, although this experimental laser-injury CNV
model is frequently used and described as a model for neo-
vascular AMD, the acute laser injury occurs in the setting of
healthy RPE cells, in contrast to the chronic disease process in
AMD. Thus, an understanding of the spatiotemporal cellular
events that occur after laser injury at the RPEechoroid
interface is important, both to allow drawing comparisons
between this acute laser-injury model and the chronic
pathology of neovascular AMD and to gain insights into the
role of various cell populations during the early wound
healing response. Here, we characterize the spatiotemporal
cellular events in laser injury-induced CNV and provide
evidence for a critical role of macrophages in the early wound
healing response and ﬁbrovascular scar formation.
Materials and Methods
Animals
C57BL/6 control mice and lysozyme M Cre, R26-stopﬂ/ﬂ-
EYFP, Itgam-Dtr, VMD2-Cre, Stat6/, and l10/ mice
were obtained from the Jackson Laboratory (Bar Harbor,
ME).9e15 VMD2-Cre mice, which express Cre in the RPE
postnatally, and lysozyme M Cre mice were crossed
with R26-stopﬂ/ﬂ-EYFP mice for cell-lineage tracing exper-
iments in RPE cells and myeloid cells, respectively, and with
Vegfaﬂ/ﬂ mice to generate mice that are null for VEGF-A
in the RPE and the myeloid lineage.16 Efﬁcient Cre-
mediated excision of the ﬂoxed VEGF-A allele in
myeloid cells with lysozyme M Cre mice has been
demonstrated.17,18 Cre expression in RPE cells that are
homozygous for the ﬂoxed VEGF-A was assessed by
immunolabeling for Cre using a monoclonal mouse anti-
Cre antibody (clone 2D8; EMD Millipore, Billerica,
MA). The generation of VegfalacZKI/WT, Vegfaﬂ/ﬂ,
Flk1lacZKI/WT, and Flt1lacZKI/WT mice has been described
previously.19e21 To ablate macrophages in Itgam-Dtr
transgenic mice or lysozyme M Cre Dtrﬂ/ﬂ mice, 20 ng/g
body weight diphtheria toxin (List Biological Laboratories,
Campbell, CA) was injected intraperitoneally at 1 day
before laser induction and 1 day after laser injury.
Immunolabeling
For all immunolabeling experiments, eyes of at least ﬁve mice
for each time point or genotype studied were used and2408consistent results were obtained. Representative immunolab-
eling images are shown. Eyes were enucleated andﬁxed in 4%
paraformaldehyde. For choroidal ﬂat mounts, eyes were per-
meabilized in 0.5% Triton X and subsequently blocked with
serum in which the secondary antibodies were raised. For
frozen sections, eyes were treated with 30% sucrose and
subsequently embedded in optimal cutting temperature cutting
compound and cut at 7-mm thickness. Tissue permeabilization
was performed with 0.25% Triton X, and blocking was per-
formed with blocking serum in which the secondary antibody
was raised. Primary antibodies used were: rat anti-mouse
CD31 (MEC13.3; BD Pharmingen, San Diego, CA), rabbit
anti-mouse b-galactosidase (A11132; Life Technologiese
Invitrogen, Carlsbad, CA), mouse monoclonal SMA-Cy3
conjugate (clone 1A4; Sigma-Aldrich, St. Louis, MO),
rabbit anti-mouse NG2 (AB5320; EMDMillipore), goat anti-
mouse arginase 1 (sc-18354; SantaCruzBiotechnology, Santa
Cruz, CA), rat anti-mouse F4/80 (CL8940AP; Cedarlane
Laboratories, Burlington, ON), rat anti-mouse F4/80eAlexa
Fluor 647 conjugate (clone C1:A3-1; BioLegend, San Diego,
CA), rabbit antiephospho-histone H3 (Ser10) (06-570; EMD
Millipore), goat anti-mouse IL-1b (AF-401NA; R&D
Systems,Minneapolis,MN), rabbit anti-mouseGFP (A11132;
Life TechnologieseInvitrogen), mouse anti-Cre (clone 2D8;
EMD Millipore), and rat anti-mouse CD144 (550563, BD
Pharmingen). The antibody to YM1 was generously provided
by Dr. Shioko Kimura (NIH, Bethesda, MD). Secondary
antibodies used were Alexa Fluor 488, Alexa Fluor 555, or
Alexa Fluor 647 (Life TechnologieseInvitrogen). Colabeling
experiments were combined with single-labeling experiments
and with experiments omitting either the primary or the
secondary antibodies, to distinguish immunolabeling from
autoﬂuorescence. DAPI (Life TechnologieseInvitrogen) was
used for staining of nuclei. Staining forb-galactosidase (b-gal)
activity was performed as described previously.22
Microarray Analyses and Semiquantitative RT-PCR
Adult C57BL/6 control mice were used for experiments in
which both eyes were exposed to laser photocoagulation,
with 14 laser spots per eye. For each mouse, after removal
of the retina, RPEechoroid tissue of both eyes was pooled
and used for RNA isolation. Groups of mice (n Z 3) were
exposed to laser photocoagulation, and RNA was isolated
from their RPEechoroid tissues separately at 0, 68, and 116
hours after laser injury. RPEechoroid tissues were lysed in
RNeasy lysis buffer (Qiagen, Valencia, CA) using a Qiagen
TissueLyser II disruption system at 30 Hz for 5 minutes.
RNA isolation was performed with an RNeasy Plus kit with
DNase treatment (Qiagen). Affymetrix mouse 430 2.0
microarray chips (Affymetrix, Santa Clara, CA) were used
for expression proﬁling experiments, and analysis was
performed with the associated dCHIP software version
2010.01. Data were analyzed for differentially expressed
candidate genes of interest, whose signiﬁcance was assessed
by determining overexpression of the protein and theajp.amjpathol.org - The American Journal of Pathology
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were performed in triplicate for each group of mice.
RPEechoroid tissue lysates of age- and gender-matched
wild-type, Il10/, and Stat6/mice and of mice that either
express or do not express diphtheria toxin receptor (DTR) in
the myeloid lineage were used for semiquantitative RT-PCR
experiments (n Z 3 mice per group). cDNA was obtained
using 100 ng total RNA with a Transcriptor ﬁrst-strand
cDNA synthesis kit (Roche Applied Science, Branchburg,
NJ) using hexamer primers. Gene expression was quantiﬁed
by semiquantitative RT-PCR using a LightCycler 480 system
with the LightCycler 480 SYBR Green I master mix (Roche
Applied Science, Indianapolis, IN). Primers used for mouse
36B4 as normalization control were m36B4-Forward 50-
TCACTGTGCCAGCTCAGAAC-30 and m36B4-Reverse
50-AATTTCAATGGTGCCTCTGG-30. Primers used for
arginase 1 (Arg1), CCL17, IL1RA (IL-1R antagonist),
inducible nitric oxide synthase (iNOS), F4/80, and CD68
were as described previously.23e26 Concentrations were
determined using a standard dilution curve. Experiments for
all samples were performed in triplicate, and reverse tran-
scriptase was omitted for negative controls.
Western Blotting
RPEechoroid tissue lysates were used for Western blotting
experiments. Freshly dissected posterior eye poles (RPEe
choroid tissue after removal of the lens, retina, and anterior
eye along the ora serrata) were lysed in NP40 lysis buffer
(Life TechnologieseInvitrogen) with 1 mmol/L phenyl-
methylsulfonyl ﬂuoride and protease inhibitor cocktail
(cOmplete; Roche Applied Science) using Qiagen Tissue-
Lyser II. After centrifugation, the supernatant was used for
Western blotting. Total protein was determined by the
Bradford method (Bio-Rad Laboratories, Hercules, CA), and
equal amounts of protein (50 mg) were loaded onto NuPage
4% to 12%Bis-Tris gels (Life TechnologieseInvitrogen) and
blotted to nitrocellulose membranes. Equal protein loading
was assessed using an anti-tubulin antibody. For detection of
Arg1 protein levels, a goat anti-mouse Arg1 antibody (sc-
18354; Santa Cruz Biotechnology) was used. Horseradish
peroxidaseeconjugated secondary antibodies were used, and
chemiluminescence signal was determined with SuperSignal
West Pico chemiluminescent substrate (Pierce; Thermo
Fisher Scientiﬁc, Rockford, IL).
Experimental CNV Model
Eyes of age- and gender-matched mice were exposed to
laser photocoagulation for induction of experimental CNV
after eyes had been dilated with 1% tropicamide and the
mice had been anesthetized with 75 mg/kg ketamine and 7.5
mg/kg xylazine. Laser photocoagulation was performed
using a 532-nm laser (Visulas 532S; Carl Zeiss Meditec,
Dublin, Ireland) attached to a slit lamp, and a coverslip was
applied to the cornea to view the retina. Lesions wereThe American Journal of Pathology - ajp.amjpathol.orginduced using a power of 200 mW, a spot size of 50 mm,
and a duration of 100 ms. The lesions were located at the 2,
6, and 10 o’clock meridians centered on the optic nerve and
two to three disc diameters away from the optic nerve.
Laser-induced disruption of Bruch’s membrane was identi-
ﬁed by the appearance of a bubble at the site of photoco-
agulation. Laser spots that did not result in the formation of
a bubble were excluded from the studies. Eyes were ﬁxed
and examined at various time points after laser treatment.
Quantitation of the Size of CNV Lesions
At 10 days after laser injury, the size of CNV lesions was
measured in choroidal ﬂat mounts from lysozyme M Cre
Vegfaﬂ/ﬂ and lysozyme M Cre control mice of the same age
and gender (nZ 10 per group). The eyes were enucleated and
ﬁxed in 4% paraformaldehyde. The anterior segment, lens,
and retina were removed, and the RPEechoroid tissue
(posterior eye) was used for immunolabeling with anti-CD31
antibodies to detect blood vessels (Alexa Fluor 488 secondary
antibody) and with SMA-Cy3 antibodies. After immunolab-
eling, four relaxing radial incisions were made in the
RPEechoroid tissue, and the tissue was ﬂat-mounted using
ProLong Gold mounting medium (Invitrogen). Choroidal ﬂat
mounts were analyzed by epiﬂuorescence microscopy using
a Zeiss microscope (Carl Zeiss Microscopy, Jena, Germany);
images were obtained with a 10 objective. CNV lesions
were identiﬁed by smooth-muscle actinepositive (SMAþ)
laser spots, and neovascular area (CD31þ staining) per CNV
lesion was determined using Zeiss AxioVision software
version 4.8.2. Average CNV size was determined for each
mouse, and differences between mutant and control mice
were assessed by Student’s t-test.
Results
Macrophages Inﬁltrate the Site of Laser Injury before
the Formation of a Myoﬁbroblastic Scaffold and
Subsequent Neovascularization
Laser injury to the RPEechoroid interface was induced in
wild-type mice, and choroidal ﬂat mounts were used at
various time points for immunolabeling experiments. F4/80þ
macrophages inﬁltrated the site of injury within the ﬁrst 24 to
40 hours (Figure 1A). Subsequently, adjacent to the site of
laser injury and in close contact with inﬁltrating macro-
phages, RPE cells exhibited strong expression of smooth
muscle actin (SMA) at approximately 48 hours after injury
(Figure 1B), a cellular response to injury and an indicator of
an epithelialemesenchymal transition (EMT)-like change.
Distinct from the SMAþ RPE cells, stellate-appearing myo-
ﬁbroblastic cells with strong expression of SMAwere seen in
CNV lesions at approximately 60 hours after injury
(Figure 1C), whereas macrophage accumulation increased to
become the predominant cell type in CNV lesions at day 3
after injury (Figure 1D). At approximately day 4, endothelial2409
Figure 1 Formation of a ﬁbrovascular network after laser injury. A: At the site of laser injury (asterisk), F4/80þ macrophages (arrowheads), are seen
within 24 to 40 hours. B: Adjacent to inﬁltrating F4/80þ macrophages (arrowhead), RPE cells exhibit increased SMA expression (arrow) at approximately 48
hours after laser injury (asterisk). C: SMAþ stellate-like cells (arrow) are seen originating from the center of laser spots at approximately 60 hours after injury
(asterisk). At that time RPE cells (arrowhead) adjacent to the injury site exhibit strong SMA expression. D: At approximately 72 hours after laser injury,
F4/80þ macrophages (arrowhead) are the predominant cell population within the area of injury (asterisk); SMAþ cells are also present (arrow). E: At
approximately 72 hours, a SMAþ myoﬁbroblastic scaffold is seen and adjacent RPE cells are SMAþ, but endothelial cells have not yet inﬁltrated the site of laser
injury. F: At approximately 96 hours, CD31þ neovessels (arrow) can be observed at the center of the site of laser injury. G and H: Between day 4 and 5 after
laser injury, a fully formed ﬁbrovascular lesion can be observed, with an extensive network of CD31þ neovessels (arrow). I and J: Confocal microscopy of a fully
formed CNV lesion at day 10 after laser injury shows that neovessels are covered and demarcated by a SMAþ myoﬁbroblastic network. Neovascularization does
not extend beyond the SMAþ myoﬁbroblastic network. K and L: Top (K) and midportion (L) of lesion at 10 days after laser injury. M: SMA expression is
maintained in RPE cells adjacent to the site of laser injury, even 4 months after injury. NeQ: Staining of a CNV lesion at 72 hours after laser injury for the
proliferation marker phospho-histone H3 (Ser10) exhibits extensive proliferation of multiple cell types within an early CNV lesion (N). Some F4/80þ cells stain
strongly for this proliferation marker (O), as well as stellate SMAþ myoﬁbroblastic cells (P) and adjacent SMAþ RPE cells (Q). Original magniﬁcation: 10 (EeI,
M, and N); 20 (AeD); 40 (K, L, OeQ).
He and Marneroscells formed a CD31þ neovascular network at the wound site,
corresponding to a choroidal neovascularization (CNV)
lesion (Figure 1, EeH). In fully formed CNV lesions, the
SMAþ myoﬁbroblastic scaffold covered the entire neo-
vascular area (Figure 1, IeL), and neovascularization did not
extend beyond this ﬁbrovascular scaffold, which thus served
to demarcate the area of neovascularization. Notably, SMA
expression in RPE cells adjacent to the site of laser injury
remained high even several months after the laser injury
(Figure 1M).2410Active Proliferation of Epithelial Cells, Macrophages,
and Fibroblastic Cells in Evolving Fibrovascular Lesions
Next, we determined which cell populations undergo active
proliferation in evolving ﬁbrovascular lesions after laser
injury. Immunolabeling for the proliferationmarker phospho-
histone H3 (Ser10) showed that some F4/80þ macrophages
undergo proliferation in CNV lesions (Figure 1, N and O).
Myoﬁbroblastic stellate-like cells exhibited active prolif-
eration with a strong signal for the proliferation markerajp.amjpathol.org - The American Journal of Pathology
Figure 2 Macrophages are required for the early wound healing response in CNV lesions. A and B: Cell-fate tracing experiments in laser-induced CNV lesions.
EYFP expression in cells of the myeloid lineage (lysozyme M Cre R26-stopﬂ/ﬂ-EYFP ﬂoxed mice) and colabeling for the vascular endothelial cell marker CD144 (VE-
cadherin) showed that myeloid cells do not transdifferentiate into vascular endothelial cells. No colabeling was observed between EYFP and CD144. A shows a three-
dimensional reconstruction of confocal microscopy images of a CNV lesion from these mice. C: Immunolabeling for F4/80 (macrophages) and CD144 (endothelial
cells) showed that macrophages and endothelial cells are both present in close proximity within CNV lesions, but no cells coexpressed both cell markers. D: Cell-fate
tracing experiments in mice that express EYFP in RPE cells (arrow) showed that the SMAþ ﬁbroblastic-scaffold (arrowhead) is not derived from RPE cells (EYFP). E:
At 66 hours after laser injury, no CD31þ endothelial cells have inﬁltrated the site of laser injury, whereas the SMAþmyoﬁbroblastic cells exhibit strong staining for
NG2 at the site of laser injury. F: In fully formed CNV lesions at day 5, a prominent SMAþNG2þmyoﬁbroblastic scaffold persists, whereas F4/80þmacrophages fully
populate the site of laser injury. G: SMAþNG2þ cells participate in the myoﬁbroblastic scaffold and also surround formed neovessels, consistent with a pericyte-like
function. H and I: While RPE cells adjacent to the laser injury site were SMAþNG2, the myoﬁbroblastic scaffold was demarcated by SMAþNG2þ staining. J:
Macrophages remain an abundant cell population even after the formation of neovessels. Three-dimensional reconstruction of confocal images. K: The area of
neovascularization does not extend beyond the area of the SMAþ myoﬁbroblastic scaffold. LeN: Ablation of macrophages in Itgam-Dtr mice with injection of
diphtheria toxin at days 1 and þ1 after laser injury showed that effective attenuation of macrophages correlates with inhibition of the formation of the
ﬁbrovascular scaffold and SMA expression in adjacent RPE cells. Original magniﬁcation: 10 (FeI, K); 20 (A, B, E, J, LeN); 40 (C, D).
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Table 1 Gene Expression Proﬁling Reveals Alternative Activation
of Macrophages in Laser-Induced Wound Healing
Marker
Fold change
0 vs 68 hours 68 vs 116 hours
Pan-macrophage markers
CD68 4.14 1.03
CD11b 5.62 1.27
M2-type markers
Arg-1 81.23 13.23
YM1 14.95 2.25
CCL17 10.53 1.68
IL-1RA 24.36 1.42
M1-type markers
iNOS 1.06 2.19
TNF-a 1.30 1.03
CXCL9 1.30 1.07
CXCL11 1.23 1.05
IL-12A 1.03 1.12
Growth factors
VEGF-A 1.16 1.02
IL-1b 3.03 2.56
Gene expression proﬁling reveals that inﬁltrating macrophages in laser-
induced CNV lesions are alternatively activated (M2-type macrophages),
with strong upregulation of the prototypic M2-type markers arginase 1
(Arg-1, >80-fold) and YM1. Inﬁltration of alternatively activated macro-
phages into CNV lesions peaks at approximately 68 hours. IL-1b transcripts
were also upregulated at 68 hours after laser injury. n Z 3 per group.
He and Marnerosphospho-histone H3 (Ser10) as well (Figure 1, N and P).
Furthermore, some RPE cells adjacent to the injury site
exhibited positive staining for this proliferation marker
(Figure 1, N and Q). Although RPE cells are normally
a quiescent cell population in the eye, these data show that
laser injury can activate RPE cells and stimulate their
proliferation. However, this RPE proliferation did not allow
for reepithelialization of the injury site. Even 4 months after
laser injury, the site of RPE cell ablation and Bruch’s
membrane disruption was not covered by RPE cells
(Figure 1M). This is not surprising, given that laser injury
disrupts the underlying basement membrane of RPE cells,
which is required for epithelial cell migration.
Cell-Lineage Tracing Experiments after Laser-Induced
Wounding
The time-course experiments showed that macrophages are
the dominant cell type present in evolving CNV lesions after
laser injury at day 3, whereas a neovascular network forms at
day 4. Some studies have suggested that myeloid progenitor
cells can transdifferentiate into endothelial cells and become
part of neovessels.4,5 To test whether this occurs in laser-
induced CNV lesions, mice were generated that express an
EYFP reporter in all cells derived from themyeloid lineage by
crossing lysozymeM Cre mice with R26-stopﬂ/ﬂ-EYFP mice.
CNV laser injury experiments in these mice showed that
macrophages align in close proximity to CD144þ (VE-cad-
herin) vascular endothelial cells in formed CNV lesions, but2412they do not incorporate into neovessels or transdifferentiate
into endothelial cells, because no colocalization of EYFP and
the vascular endothelial-speciﬁc marker CD144was observed
(Figure 2, A and B). Similarly, colabeling experiments for the
macrophage marker F4/80 with the vascular endothelial
marker CD144 conﬁrmed these ﬁndings (Figure 2C).
The time-course experiments showed that RPE cells adja-
cent to the injury site exhibit strong expression of SMA, and
subsequently stellate SMAþ cells form a ﬁbroblastic scaffold
that eventually demarcates and covers the entire CNV lesion.
To test whether these SMAþ cells are derived from an EMT-
like process from SMAþ RPE cells, cell lineage-tracing
experiments for RPE cells in CNV lesion were performed,
by generating mice that express an EYFP reporter in cells
derived from RPE cells. For this purpose, Vmd2-Cre mice,
which express Cre recombinase in RPE cells, were crossed
with R26-stopﬂ/ﬂ-EYFP mice, and these mice were used for
CNV laser-injury experiments. EYFP expression was
observed in RPE cells but not in the stellate SMAþ cells,
indicating that these cells are not derived from an EMT-like
transition from activated RPE cells (Figure 2D).
The Myoﬁbroblastic Scaffold in CNV Lesions Consists of
NG2þSMAþ Cells
The cell-lineage tracing experiments suggest that the myo-
ﬁbroblastic scaffold originates from cells of the underlying
choroid, such as pericyte-like cells. Immunolabeling for
NG2, which is commonly expressed by pericytes, showed
that the ﬁbroblastic scaffold at the center of CNV lesions
consists of cells that are positive for SMA and NG2, but the
adjacent RPE cells express only SMA at high levels
(Figure 2, EeG). Notably, NG2þSMAþ cells were observed
in CNV lesions before inﬁltration of the site with endothelial
cells (Figure 2E). In fully formed CNV lesions, NG2þSMAþ
cells were seen as part of the myoﬁbroblastic scaffold and in
a perivascular arrangement surrounding neovessels, such as
would be expected for pericytes (Figure 2, GeK).
Macrophages Promote the Formation of the
Fibroblastic Scaffold in Early CNV Lesions
The observation that macrophage inﬁltration precedes the
formation of this SMAþNG2þ myoﬁbroblastic scaffold and
that RPE cells exhibit induced SMA expression in close
proximity to macrophages suggests that these macrophages
promote these changes in evolving ﬁbrovascular CNV
lesions. To test this hypothesis, macrophages were tempo-
rally ablated in this model, using Itgam-Dtr transgenic mice.
In these mice, the diphtheria toxin receptor, DTR [alias
heparin-binding EGF-like growth factor (HBEGF)], is
expressed under the control of the ITGAM promoter, which
is expressed in macrophages, and injection of diphtheria
toxin results in reversible ablation of macrophages in these
mice.15 Consistent with these observations, ablation of
macrophages in these transgenic mice resulted in inhibitionajp.amjpathol.org - The American Journal of Pathology
Macrophages in Fibrovascular Scarringof SMA expression in RPE cells after laser injury and
delayed formation of the SMAþNG2þ myoﬁbroblastic
scaffold (Figure 2, LeN). Similar observations were made
using lysozyme M Cre Dtrﬂ/ﬂ mice instead of Itgam-Dtr
transgenic mice, in which DTR is expressed in all myeloid
cells, further conﬁrming that macrophages promote forma-
tion of the myoﬁbroblastic scaffold during the early wound
healing response (data not shown). Thus, the observed early
changes in CNV lesions require inﬁltrating myeloid cells.The American Journal of Pathology - ajp.amjpathol.orgMacrophages in CNV Lesions Undergo Alternative
Activation Independently of IL-4/STAT6 or IL-10
Signaling
Global gene-expression proﬁling experiments with eyes of
wild-type mice at 0, 3, and 5 days after laser injury showed
that inﬁltrating macrophages are alternatively activated
(Table 1 and Supplemental Tables S1 and S2), with strong
induction of markers for alternative activation of macro-
phages (M2-type macrophages), including Arg1 (Arg1) and
YM1, which peaked at day 3 after laser injury (Table 1).
These data were conﬁrmed by semiquantitative RT-PCR and
by Western blotting of choroidal tissue lysates after laser
injury (Figures 3A and 4). IL-1b expression was also signif-
icantly up-regulated at 3 days after laser injury, but decreased
at day 5 (Table 1). Increased IL-1b in CNV lesions was
conﬁrmed by immunolabeling (Figure 5H). Notably, the
NG2þSMAþmyoﬁbroblastic scaffold in laser lesions stained
strongly for IL-1b, whereas no strong staining was seen in
wound macrophages (Figure 5H). Immunolabeling for Arg1,
YM1, and F4/80 conﬁrmed that most macrophages that
accumulate at sites of laser injury are alternatively activated
M2-like macrophages, whereas nonlesional choroidal F4/80þ
cells were Arg1YM1 (Figure 3, BeD).
Alternative activation of macrophages has been reported in
acute skin wound healing experiments, in which alternative
activation occurs independent of IL-4/STAT6 signaling,
which is a major pathway mediating alternative activation of
macrophages, as is the IL-10 signaling pathway.27 As in
acute wound healing models in the skin, alternative activa-
tion of macrophages occurs in laser-induced CNV indepen-
dent of IL-10 and the IL-4/STAT6 pathway; in STAT6 and
IL-10 null mice, Arg1þYM1þ macrophages accumulated in
CNV lesions (Figure 3, EeH). In mutant mice in which
macrophages expressed DTR and that were treated with
diphtheria toxin to ablate macrophages, Western blotting of
laser-treated choroidal tissue lysates conﬁrmed that the
increase of Arg1 protein levels is due to increased expression
in activated inﬁltrating macrophages in a process that does
not require STAT6 or IL-10 signaling (Figure 3H).Figure 3 Macrophages in laser-induced CNV lesions are alternatively acti-
vated, independent of IL-4/STAT6 or IL-10 signaling. A: Western blotting of
choroidal tissue lysates reveals up-regulation of the M2-type marker Arg1 at day
3after laser-inducedwound injury.B: Immunolabeling for F4/80andArg1 shows
that in CNV lesions the majority of macrophages are Arg1þ (arrow) at approx-
imately 72 hours after injury; however, quiescent choroidal macrophages do not
express Arg1 (arrowhead). C: Macrophages inﬁltrating CNV lesions exhibit
colabeling for F4/80 and Arg1 (whole-mount confocal microscopy image). D: In
controlmice,macrophages in fully formedCNV lesionsare F4/80þArg1þ.EandF:
In Stat6/ macrophages (F4/80þ) can be seen in laser-induced CNV lesions to
express YM1 (E) and Arg1 (F). G: In IL-10 null mice (Il10/) Arg1þ F4/80þ
macrophages are present in laser-induced CNV lesions.H: Arg1 protein levels are
increased at day 3 after wound injury in choroidal lysates wild-typemice, as well
as in Stat6/ and Il10/mice. Depletion ofmyeloid cells (DTRþ) prevents the
increase of choroidal Arg1 levels, demonstrating that the observed arginase
increase is due to macrophage inﬁltration. DTR, Dtrﬂ/ﬂ mice treated with
diphtheria toxin; DTRþ, lysozyme M Cre Dtrﬂ/ﬂ mice treated with diphtheria
toxin. Original magniﬁcation: 10 (B);20 (CeG).
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Figure 4 Inﬁltrating wound macrophages express markers of M2-type macrophages. Semiquantitative RT-PCR of RPEechoroid tissue lysates obtained
immediately after laser injury or 3 days later. A and B: The pan-macrophagemarkers F4/80 (A) and CD68 (B) were signiﬁcantly increased 3 days after laser injury in
wild-type mice and in IL-10 and STAT6 null mice. Relative mRNA levels are indicated normalized to m36B4 levels. CeF: The M1-type macrophage marker iNOS (C)
was down-regulated 3 days after laser injury (normalized to either m36B4 or to the total macrophage population using F4/80 mRNA levels), whereas the M2-type
markers Arg1 (D), CCL17 (E), and IL1RA (F) were signiﬁcantly up-regulated. Data are expressed as means  SD. *P < 0.05, **P < 0.01, and ***P < 0.001.
He and MarnerosTo characterize the inﬁltrating macrophage population
after laser injury and to quantitate the results obtained from the
gene expression proﬁling and immunolabeling experiments,
semiquantitative RT-PCR for macrophage markers was per-
formed using RNA isolated from choroidal tissue lysates
3 days after laser injury at baseline. A signiﬁcant increase in
the macrophage population in choroidal tissue lysates after
laser injury was observed in control and IL-10 and STAT6
null mice, with strongly increased expression of the macro-
phage markers F4/80 and CD68 (Figure 4, A and B).
Expression of theM1-typemarker iNOSwas down-regulated
(Figure 4C), whereas theM2-typemarkers Arg1, CCL17, and
IL1RA were signiﬁcantly up-regulated (Figure 4, DeF).
Thus, immunolabeling,Western blotting, and semiquantitative
RT-PCR experiments all clearly demonstrate that the inﬁl-
trating macrophages during the early wound healing response
after laser injury are M2-type macrophages.
Conditional inactivation of PPAR-g or IKK-b (NF-kB
signaling) in themyeloid lineage, which have been implicated
in the formation of M2-type macrophages, did not prevent
alternative activation of macrophages in laser-induced CNV
lesions as well (data not shown). These ﬁndings suggest
that either additional signaling pathways are involved in
promoting alternative activation of macrophages in response
to laser injury or that compensation mechanisms among these
pathways are present, and that targeting a single pathway can
be compensated for by other pathways involved in this
process.2414RPE- or Macrophage-Derived VEGF-A Is Not Required
for Neovessel Formation in CNV
It has been proposed that inﬁltrating macrophages express
VEGF-A and promote neovascularization in CNV models
and in neovascular AMD.7 In another study, however, no
VEGF-A expression was observed in macrophages in neo-
vascular AMD lesions in patients, although VEGF-A
expression was observed in RPE cells.8
To assess whether macrophages or RPE cells ex-
press VEGF-A in CNV lesions, VEGF-A reporter mice
(VegfalacZKI/WTmice) were used, in which an NLS-lacZ allele
was introduced into the 30UTR of the VEGF-A gene.19 In
these mice, nuclear b-gal actosidase (b-gal) staining reﬂects
VEGF-A expression at a cellular resolution and allows precise
characterization of the cellular origin of VEGF-A expression.
In quiescent RPEechoroid tissues, these VegfalacZKI/WT mice
exhibited strong expression of VEGF-A in adult RPE cells;
however no b-gal staining was seen in choroidal cells
(Figure 5, A and B). The choroidal vessels did not express
VEGF-A, but exhibited strong expression for both VEGF-A
receptors Flt1 and Flk1, as demonstrated with b-gal stain-
ing of eyes of Flt1lacZKI/WT mice and Flk1lacZKI/WT mice
(Figure 5, C and D).
Laser-induced CNV in VegfalacZKI/WT mice revealed that
RPE cells maintain strong expression of VEGF-A in CNV
lesions (b-galþ), whereas no b-gal expression was seen in
endothelial cells of forming vessels (Figure 5E). Importantly,ajp.amjpathol.org - The American Journal of Pathology
Figure 5 Expression of VEGF-A and IL-1b in CNV lesions. A: Removal of RPE cells in choroidal ﬂat mounts (top part of A), shows that only RPE cells express
VEGF-A (b-galþ), while underlying choroidal cells are b-gal. A and B: In adult RPE cells (arrow), VEGF-A is strongly expressed, although the underlying choroidal
cells exhibit no evidence of VEGF-A expression in VegfalacZKI/WT mice. C: Expression of the VEGF-A receptor Flt1 is prominent in quiescent choroidal vessels, shown
here by b-gal staining in Flt1lacZKI/WT mice. D: Similarly, expression of the VEGF-A receptor Flk1 can be seen in choroidal vessels, shown here by b-gal staining in
Flk1lacZKI/WT mice. EeH: In immunolabeling experiments for b-gal in VegfalacZKI/WT mice, nuclear b-gal staining identiﬁes the cells that express VEGF. E: Blood
vessels and the SMAþmyoﬁbroblastic cells within CNV lesions exhibit no strong VEGF-A expression (b-gal), whereas the adjacent RPE cells exhibit strong VEGF-A
expression (b-galþ). F: No VEGF-A signal was seen in F4/80þ macrophages in CNV lesions. G: Although F4/80þ macrophages (arrow) exhibit no nuclear b-gal
staining, adjacent RPE cells exhibit strong VEGF-A expression (arrowhead). H: No VEGF-A expression is seen within CNV lesions in VegfalacZKI/WT mice. At 72 hours
after laser injury, inﬁltrating macrophages exhibit no IL-1b expression or expression only in a few cells, whereas the non-myeloid cells in the CNV lesions exhibit
strong expression for IL-1b. I and J: Conditional inactivation of VEGF-A in RPE cells postnatally shows that fully formed neovascular lesions can form despite Cre
expression in RPE cells. K: Genetic inactivation of VEGF-A in myeloid cells does not prevent CNV lesion formation. L: CNV lesions exhibit no signiﬁcant difference
in neovascular area in mice that lack VEGF-A expression in myeloid cells, compared with age- and gender-matched lysozyme M Cre control mice. Data are expressed
as means  SD. nZ 10 per group. Original magniﬁcation: 10 (A, B, F, K); 20 (C, D, E, J, K); 40 (G).
Macrophages in Fibrovascular Scarringlesional F4/80þ macrophages exhibited no expression of
b-gal (Figure 5, F andG), and targeted ablation of VEGF-A in
macrophages did not prevent CNV lesion formation, pro-
viding additional evidence that macrophages may promote
neovascularization independently of VEGF-A in CNV
(Figure 5, K and L). Furthermore, fully formed lesional
neovessels could be seen in mice that lacked VEGF-A
expression in the RPE (Figure 5, I and J).
Discussion
The present ﬁndings demonstrate that the experimental laser
injury-induced CNVmodel of neovascular AMD shows all the
characteristics of an acute wound healing response of the
RPEechoroid interface, rather than resembling the chronic
pathologies seen in neovascularAMD.A scar-like formation ofThe American Journal of Pathology - ajp.amjpathol.orga myoﬁbroblastic scaffold that covers and demarcates the site
of neoangiogenesis is observed, this scaffold formation being
promoted by alternatively activated macrophages. These M2-
type macrophages resemble wound macrophages, as seen for
example in skin wounding experiments.27 Similarly, as
observed in this laser-injury model in the eye, early ablation of
macrophages during cutaneous wound healing inhibited
myoﬁbroblast differentiation in the wound bed.28 Furthermore,
as reported in these skin wound healing experiments, IL-4/
STAT6 signaling was not required for alternative activation
of macrophages in this laser-injury CNV model. In contrast,
a preliminary study showed that a mixed population of
macrophages is present in AMD lesions, and not a predominant
M2-type population.29 These differences need to be considered
when the laser-injury CNVmodel is used to draw comparisons
with disease processes involved in neovascular AMD.2415
He and MarnerosTheM2-typemacrophages that appear after laser injurymay
promote angiogenesis directly or indirectly through various
growth factors and cytokines. However, macrophage-derived
VEGF-A is not required for CNV lesions to form; no high-
level VEGF-A expression was observed in macrophages in
CNV lesions, and targeting VEGF-A in the myeloid lineage
did not inhibit neovascularization signiﬁcantly. Notably, RPE
cells strongly expressVEGF-Aandmaypromote angiogenesis
locally. However, ablation of VEGF-A in RPE cells did not
prevent CNV lesion formation, further suggesting that factors
other than RPE-derived or myeloid cellederived VEGF-A
may promote CNV at the site of laser injury. The targeted
ablation of VEGF-A speciﬁcally in RPE cells is limited by the
fact that RPE-expressing Cre mouse strains, including the
VMD2-Cre mice used in the present study, exhibit a patchy
and nonuniform pattern of Cre expression in the RPE cell
layer, which limits quantitative comparisons among CNV
lesions in these mutant mice and control mice. However, fully
formed CNV lesions with extensive neovascularization were
frequently observed at sites in which the vast majority of the
RPE cells strongly expressed Cre, suggesting that VEGF-A in
RPE cells is not required for CNV lesion formation.
Notably, in full-thickness skinwound healing experiments,
macrophages were shown to express VEGF-A mainly during
the early phases of the wound healing response, whereas
during the later stage of wound healing the wound-edge
epithelium was a main source of VEGF-A.18 These experi-
ments also showed that VEGF-A from both cell com-
partments had complementary roles in promoting wound
angiogenesis.18 Thus, although eithermyeloid- or epithelium-
derived VEGF-A promotes wound angiogenesis in the skin,
neither RPE- or macrophage-derived VEGF-A appears to be
critical for laser-inducedCNV in the posterior eye, suggesting
tissue-speciﬁc differences in the wound healing response.
Although VEGF-Awas not expressed in the wound center,
strong expression of the proangiogenic factor IL-1b in cells of
the ﬁbrovascular scaffold was observed, suggesting that
IL-1b may promote subsequent neovascularization. Consis-
tent with this observation, it has been shown in some exper-
imental models that IL-1b has potent proangiogenic activity
and that this activity requires the presence of activated
macrophages.30 Importantly, IL-1b has also been shown to
promote laser-induced CNV.31,32 Furthermore, CNV speci-
mens from patients with neovascular AMD were shown
to contain a large number of IL-1b expressing cells.8 In
summary, the present ﬁndings demonstrate an acute wound
healing response in this experimental CNV model, with clear
differences from the chronic changes in neovascular AMD.
Macrophages become alternatively activated during the early
wound healing response and play an important role for the
formation of a ﬁbrovascular scar.
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